VIVUS (STU:VIU1) Other Net Income (Loss) : €-0.00 Mil (TTM As of Mar. 2020)

View and export this data going back to . Start your Free Trial

What is VIVUS Other Net Income (Loss)?

VIVUS's Other Net Income (Loss) for the three months ended in Mar. 2020 was €-0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2020 was €-0.00 Mil.

VIVUS's quarterly Other Net Income (Loss) declined from Sep. 2019 (€0.00 Mil) to Dec. 2019 (€-0.00 Mil) and declined from Dec. 2019 (€-0.00 Mil) to Mar. 2020 (€-0.00 Mil).

VIVUS's annual Other Net Income (Loss) stayed the same from Dec. 2017 (€0.00 Mil) to Dec. 2018 (€0.00 Mil) but then declined from Dec. 2018 (€0.00 Mil) to Dec. 2019 (€-0.00 Mil).

VIVUS Other Net Income (Loss) Historical Data

The historical data trend for VIVUS's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VIVUS Other Net Income (Loss) Chart

VIVUS Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Other Net Income (Loss)

Get a 7-Day Free Trial

VIVUS Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

VIVUS Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.00 Mil.

VIVUS Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of VIVUS's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

VIVUS (STU:VIU1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VIVUS Inc (STU:VIU1) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

900 East Hamilton Avenue, Suite 550, Campbell, CA, USA, 95008

Website

http://www.vivus.com

VIVUS Inc is a US-based biopharmaceutical company engaged in developing and commercializing, next-generation therapies to address unmet medical needs in human health. Its commercial products include Qsymia, an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index; PANCREAZE which is a is a pancreatic enzyme preparation consisting of pancrelipase, an extract derived from porcine pancreatic glands, as well as other enzyme classes and STENDRA/SPEDRA, which is an oral phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction.

VIVUS (STU:VIU1) Headlines

No Headlines